Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1992 2
1993 5
1994 1
1996 6
1997 1
1998 1
1999 6
2000 2
2001 4
2002 5
2003 8
2004 4
2005 7
2006 6
2007 21
2008 29
2009 39
2010 44
2011 49
2012 46
2013 52
2014 58
2015 63
2016 52
2017 55
2018 78
2019 99
2020 93
2021 89
2022 80
2023 78
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

997 results

Results by year

Filters applied: . Clear all
Page 1
Role of B cells as antigen presenting cells.
Rastogi I, Jeon D, Moseman JE, Muralidhar A, Potluri HK, McNeel DG. Rastogi I, et al. Among authors: jeon d. Front Immunol. 2022 Sep 8;13:954936. doi: 10.3389/fimmu.2022.954936. eCollection 2022. Front Immunol. 2022. PMID: 36159874 Free PMC article. Review.
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
Koo BK, Kang J, Park KW, Rhee TM, Yang HM, Won KB, Rha SW, Bae JW, Lee NH, Hur SH, Yoon J, Park TH, Kim BS, Lim SW, Cho YH, Jeon DW, Kim SH, Han JK, Shin ES, Kim HS; HOST-EXAM investigators. Koo BK, et al. Among authors: jeon dw. Lancet. 2021 Jun 26;397(10293):2487-2496. doi: 10.1016/S0140-6736(21)01063-1. Epub 2021 May 16. Lancet. 2021. PMID: 34010616 Clinical Trial.
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea.
Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo KW, Jeon D, Lee T, Lee JY, Park JS, Lee SH, Kang YA, Lee JK, Kwak N, Ahn JH, Shim TS, Kim SY, Kim S, Kim K, Seok KH, Yoon S, Kim YR, Kim J, Yim D, Hahn S, Cho SN, Yim JJ; MDR-END investigators. Mok J, et al. Among authors: jeon d. Lancet. 2022 Oct 29;400(10362):1522-1530. doi: 10.1016/S0140-6736(22)01883-9. Lancet. 2022. PMID: 36522208 Clinical Trial.
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y; TICO Investigators. Kim BK, et al. Among authors: jeon dw. JAMA. 2020 Jun 16;323(23):2407-2416. doi: 10.1001/jama.2020.7580. JAMA. 2020. PMID: 32543684 Free PMC article. Clinical Trial.
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
Kim CJ, Park MW, Kim MC, Choo EH, Hwang BH, Lee KY, Choi YS, Kim HY, Yoo KD, Jeon DS, Shin ES, Jeong YH, Seung KB, Jeong MH, Yim HW, Ahn Y, Chang K; TALOS-AMI investigators. Kim CJ, et al. Among authors: jeon ds. Lancet. 2021 Oct 9;398(10308):1305-1316. doi: 10.1016/S0140-6736(21)01445-8. Lancet. 2021. PMID: 34627490 Clinical Trial.
Toll-like receptor agonists as cancer vaccine adjuvants.
Jeon D, Hill E, McNeel DG. Jeon D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2297453. doi: 10.1080/21645515.2023.2297453. Epub 2023 Dec 28. Hum Vaccin Immunother. 2024. PMID: 38155525 Free PMC article. Review.
Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition.
Sim JR, Shin DH, Park PG, Park SH, Bae JY, Lee Y, Kang DY, Kim YJ, Aum S, Noh SH, Hwang SJ, Cha HR, Kim CB, Ko SH, Park S, Jeon D, Cho S, Lee GE, Kim J, Moon YH, Kim JO, Nam JS, Kim CH, Moon S, Chung YW, Park MS, Ryu JH, Namkung W, Lee JM, Lee MG. Sim JR, et al. Among authors: jeon d. Cell Rep. 2022 Jul 19;40(3):111117. doi: 10.1016/j.celrep.2022.111117. Epub 2022 Jul 4. Cell Rep. 2022. PMID: 35839776 Free PMC article.
997 results